Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CVD (cardiovascular disease) gender medical technology-access divide feeds Abbott stent trial:

This article was originally published in Clinica

Executive Summary

Despite the fact that more women than men die from cardiovascular disease (CVD), women fall far behind men in terms of receiving key medtech-based care. Abbott is citing the fact to explain the reasoning behind a new trial to evaluate its Xience V everolimus-eluting stent system. The Xience V Spirit Women trial was launched last week with its first procedure, performed at the Hospital Italiano, in Buenos Aires, Argentina. Citing data from the American Heart Association and other bodies, it notes that women receive only 33% of angioplasties, stents or bypass surgery, 28% of implantable defibrillators and 36% of open-heart surgery. The trial will involve some 2,000 women at around 100 sites in Europe, the Asia Pacific region, Canada and Latin America, with a five-year follow-up.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT049298

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel